The CPHI & PMEC Pharmaceutical Industry Exhibition (Shenzhen) will grandly open from September 1 to 3, 2025, at the Shenzhen Convention and Exhibition Center (Futian). The CPHI Shenzhen exhibition will fully stimulate the internal drive and innovative vitality of pharmaceutical enterprises, inject strong development momentum into the global pharmaceutical value chain, and jointly explore new growth opportunities for the pharmaceutical industry in the Greater Bay Area and Asia.

Shandong Binzhou Zhiyuan Biotechnology Co., Ltd., along with its subsidiary Jinan Xinzhiyuan Biotechnology Co., Ltd., will appear at the CPHI & PMEC Pharmaceutical Industry Exhibition (Shenzhen) held at the Shenzhen Convention and Exhibition Center (Futian) from September 1 to 3, 2025, at Booth 9i28. They will prominently launch new products: “Hydroxypropyl Chitosan” and “Carboxymethyl Chitosan.” This participation aims to deepen industry collaboration and promote the innovative application of cyclodextrin derivatives and chitosan derivatives in fields such as pharmaceuticals and daily chemicals.

Zhiyuan Biotechnology looks forward to exchanging and collaborating with more industry peers to jointly advance innovation and development in the pharmaceutical industry. We believe that through this exhibition, Zhiyuan Biotechnology will be able to establish connections with more industry colleagues and collectively drive the prosperous development of the pharmaceutical sector. At the same time, we also look forward to meeting friends at the exhibition to discuss cooperation and create a brilliant future together!